JPMorgan lowered the firm’s price target on Colgate-Palmolive (CL) to $88 from $95 and keeps an Overweight rating on the shares as part of a Q3 preview for the household, personal care and beauty group. Most of these large cap companies in the group will likely report another weak quarter amid “still depressed” consumer demand in the U.S. and decelerating trends for Western Europe, the analyst tells investors in a research note. JPMorgan says this backdrop is further worsened by retailers taking down inventory.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CL:
- Colgate-Palmolive price target lowered to $88 from $98 at BofA
- Colgate-Palmolive price target lowered to $92 from $99 at UBS
- Colgate-Palmolive assumed with a Neutral at Piper Sandler
- Colgate-Palmolive price target lowered to $82 from $87 at Barclays
- Colgate-Palmolive (CL) Strikes $332M Settlement in Pension Class-Action